Next Article in Journal
Reliability of Measuring the Proximal Humeral Bone Mineral Density Using Dual-Energy X-ray Absorptiometry
Previous Article in Journal
Pre-Operative Adiposity and Synovial Fluid Inflammatory Biomarkers Provide a Predictive Model for Post-Operative Outcomes Following Total Joint Replacement Surgery in Osteoarthritis Patients
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Sociodemographic and Lifestyle Risk Factors Associated with Fragility Hip Fractures: A Systematic Review and Meta-Analysis

1
Musculoskeletal Translational Innovation Initiative, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
2
Department of Emergency Medicine, Metropolitan Medical Center, New York Medical College, New York, NY 10029, USA
3
Boston University School of Medicine, Boston, MA 02118, USA
4
Knowledge Services, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
5
Carl J. Shapiro Department of Orthopaedic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
6
Harvard Orthopaedic Trauma Initiative, Harvard Medical School, Boston, MA 02215, USA
7
Department of Orthopaedic Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02215, USA
8
Overlæge, Klinisk Forskningslektor, Bispebjerg Hospital, University of Copenhagen, 2400 Copenhagen, Denmark
9
Department of Orthopaedic Surgery, Yerevan State Medical University, Yerevan 0025, Armenia
*
Author to whom correspondence should be addressed.
These authors have contributed equally to this work as first authors.
Osteology 2024, 4(2), 64-87; https://doi.org/10.3390/osteology4020006
Submission received: 18 January 2024 / Revised: 14 March 2024 / Accepted: 6 May 2024 / Published: 14 May 2024

Abstract

:
Hip fractures inflict heightened morbidity and mortality upon older adults. Although previous studies have explored the impact of individual demographic factors on hip fracture risk, a comprehensive review can help reconcile disparities among these factors. This meta-analysis encompassed 69 studies involving 976,677 participants and 99,298 cases of hip fractures. We found that age ≥ 85 (OR = 1.75), BMI < 18.5 (OR 1.72), female sex (OR = 1.23), history of falls (OR = 1.88), previous fractures (OR = 3.16), menopause (OR 7.21), history of maternal hip fractures (OR = 1.61), single and unmarried status (OR = 1.70), divorced status (OR 1.38), residing in a residential care facility (OR = 5.30), and living alone (OR = 1.47) were significantly associated with an increased incidence of hip fracture. Conversely, BMI ranging from 25 to 30 (OR = 0.59), BMI > 30 (OR = 0.38), parity (OR = 0.79), non-Caucasian descent (overall OR = 0.4, Asian OR 0.36, Black OR = 0.39, and Hispanic OR = 0.45), and rural residence (OR = 0.95) were significantly associated with a diminished risk of hip fracture. Hip fracture patients exhibited significantly lower weight and BMI than the non-fracture group, while their age was significantly higher. However, age at menopause and height did not significantly differ between the two groups.

1. Introduction

Hip fractures are particularly concerning injuries since they cause considerable pain and loss of function and increase morbidity and mortality in the individual affected [1,2]. Elevated hip fracture rates are most often observed in older adults; a demographic group expected to increase in numbers significantly in the coming years [3]. Consequently, the associated rise in hip fracture rates will pose an amplified burden on healthcare systems as the population ages. For this reason, a renewed focus has been placed on determining the risk factors predisposing individuals to this injury [3,4,5].
Further, risk assessment scales have been developed to identify patients at greater risk of experiencing hip fractures. Historically, such strategies have primarily focused on bone mineral density (BMD) as measured by dual-energy X-ray absorptiometry (DXA). Although BMD is an essential element of a patient’s fracture risk profile, many demographic factors are reliable predictors of hip fracture [6]. The 10-year fracture risk assessment tool (FRAX) considers some factors, including age, weight, sex, family history, and previous fracture, in its calculation [7]. However, recent studies have shown strong links between hip fractures and other demographic factors not traditionally included in risk assessments. These include, but are not limited to, environmental factors and marital status [3,8]. While a recent systematic review and meta-analysis by Mortenson et al. sheds light on modifiable risk factors for hip fractures and provides valuable insights into factors such as weight, BMI, coffee and alcohol consumption, and smoking habits, it also highlights that existing research may not fully encompass all relevant sociodemographic factors [9].
Many studies have reported individual demographic factors impacting hip fracture risk assessment, but a comprehensive review may be appropriate. Our study brings new insights into the field by comprehensively assessing hip fracture risk factors. It includes well-known risk factors and under-researched sociodemographic and lifestyle elements, which current tools such as FRAX do not cover comprehensively. Therefore, this systematic review and meta-analysis study aims to integrate recent developments to provide a better consensus regarding sociodemographic and lifestyle risk factors for hip fracture.

2. Materials and Methods

2.1. Search Strategy and Selection Criteria

Following the published guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and the Meta-analysis of Observational Studies in Epidemiology (MOOSE) group, we searched EMBASE, PubMed Publisher, Web of Science™, Cochrane Central, and clinicaltrials.gov in September 2017. An updated search was performed in January 2022 to add all studies to date. The following keywords were used in the search: “hip”, “hips”, “fracture”, “osteoporosis”, “osteoporo”, “fragility fracture”, “risk”, “odds ratio”, and “hazard ratio” (see Appendix A, Search strategy). Furthermore, references to relevant studies were used in the search process. We included studies reporting demographic risk factors for osteoporotic hip fractures. Studies were eligible for inclusion if they met the following criteria: (1) inclusion of adult patients with osteoporotic hip fractures, (2) case-control or cohort studies, (3) full-text articles available in English, and (4) at least one year of follow-up. Meeting presentations, abstracts, reviews, case reports, and studies containing patients under eighteen were excluded from this analysis. The PICOS framework is presented in Table 1.

2.2. Screening and Data Extraction

Four investigators screened studies independently for eligibility (AM, DY, SJM, and KM). After removing duplicates, we identified 14,932 studies in the first search and an additional 4040 in the updated search, of which 69 were included in the quality assessment and data synthesis (Figure 1, Prisma flowchart). Three independent reviewers (AM, DY, and DC) utilized a standardized template to extract data, encompassing journal name, first author, publication year, span of participant enrollment, study design, country of study, number of included patients, sex ratio, mean participant age, duration of follow-up, demographic risk factors, fracture occurrences, and confounding variables adjusted for in analyses (Table 2). We carefully considered and evaluated the variables selected for this study to detect potential overlap in grouping and categorization. We assessed overlap within primary studies to ensure the inclusion of unique patient populations in the data analysis. Ultimately, the data presented by the primary papers constrain our analysis.

2.3. Statistical Analysis

We included exposures of interest consistently reported by at least two studies in the meta-analysis. We collected odds ratios (ORs) and data from exposed participants to compute pooled effect sizes and 95% confidence intervals (CIs). In cases where variables had multiple levels (e.g., body mass index and parity), we designated one level as the reference and compared the remaining levels to this reference. If only crude data were available, we converted them to odds ratios to facilitate the generation of pooled ORs. Whenever possible, we prioritized ORs derived from multivariable analyses over those from crude or unadjusted data.
To analyze continuous data such as age or body mass index (BMI), we employed the standard mean difference (or Cohen’s d) to measure effect size. This involved calculating the difference between the means of the two groups and dividing it by the pooled standard deviation to create a standardized measure of effect size. This approach allowed us to compare effect sizes across different studies. In cases where the standard deviation was not directly reported, we used estimation methods to infer it from other available statistics, such as standard error, confidence interval, or t-statistic. Similar to categorical data, we gave preference to effect sizes derived from multivariable analyses when such data were available. We considered p values below 0.05 as significant. We analyzed all data using Stata software (Stata Statistical Software: v18, StataCorp, College Station, TX, USA).
Two authors (NK and DY) assessed the methodologic quality of the studies using the Newcastle–Ottawa Scale (NOS), and a second author (KM) verified their assessments. To evaluate heterogeneity between studies, we used the I2 statistic. A random effects model was employed for the meta-analysis to calculate the pooled effects of risk factors on the risk of hip fracture. We utilized a funnel plot to assess publication bias and conducted the Egger test for risk factors when more than two studies were included [9]. We performed a sensitivity analysis in cases of publication bias. Supplementary figures, including funnel plots, are provided in Supplemental Figures S5–S17. The protocol for this study is registered at the PROSPERO register (ID = CRD42017073924).

3. Results

This meta-analysis included 69 studies containing 976,677 participants and 99,298 hip fracture cases. Cohorts reported in more than one study were only counted once when reporting the pooled number of cases and controls. The median age of the individuals included was 73.7 years (interquartile range of 53–85), and the median percentage of male participants was 25.5 (interquartile range of 0–100). In total, 66 of the 69 studies received a score of 6 or greater on the Newcastle–Ottawa Scale. The Egger test result for rank correlation was non-significant, and the funnel plot did not show asymmetry, indicating a low risk for publication bias, except for two risk factors (Table 3). The age and BMI of patients with hip fractures showed significant publication bias. Studies removed for publication bias were Anastasilakis et al. [13] regarding age and Anastasialkis et al. and Bartel et al. [13,16] regarding BMI.
The demographic risk factors significantly associated with an elevated risk of hip fracture were as follows: age ≥ 85 (OR 1.75; 95% CI 1.28, 2.38), BMI < 18.5 (OR 1.72; 95% CI 1.35, 2.18), female sex (OR 1.23; 95% CI 1.15, 1.32), history of falling (OR 1.88; 95% CI 1.43, 2.47), previous fracture (OR 3.16; 95% CI 2.08, 4.80), menopause (OR 7.21; 95% CI 4.29, 12.12), history of maternal hip fracture (OR 1.63; 95% CI 1.35, 1.98), unmarried and single (OR 1.70; 95% CI 1.38, 2.10), divorced (OR 1.38; 95% CI 1.01, 1.89), living in a residential care facility (OR 5.30; 95% CI 1.91, 14.75), and living alone (OR 1.47; 95% CI 1.15, 1.89). Age ≥ 65 (OR 1.66; 95% CI 0.40, 6.96), family history of osteoporosis (OR 0.95; 95% CI 0.68, 1.34), history of parental hip fracture (OR 1.42; 95% CI 0.94, 2.15), income quintiles (1st quintile: OR 0.86 and 95% CI 0.58, 1.28; 2nd quintile: OR 0.76 and 95% CI 0.48, 1.22; 4th quintile: OR 0.83 and 95% CI 0.56, 1.23; 5th quintile: OR 0.65 and 95% CI 0.43, 1.00), and being widowed (OR 1.36; 95% CI 0.91, 2.03) were non-significantly associated with hip fracture. Conversely, 25 < BMI < 30 (OR 0.59; 95% CI 0.45, 0.77), BMI > 30 (OR 0.38; 95% CI 0.18, 0.77), parity (≥1: OR 0.79 and 95% CI 0.69, 0.92; 1 ≤ parity < 3: OR 0.8 and 95% CI 0.71, 0.91; ≥3: OR 0.77 and 95% CI 0.63, 0.93), non-Caucasian descent (overall OR 0.4 and 95% CI 0.31, 0.52; Asian OR 0.36 and 95% CI 0.27, 0.48; Black OR 0.39 and 95% CI 0.23, 0.66; Hispanic OR 0.45 and 95% CI 0.33, 0.63), and rural residence (OR 0.95; 95% CI 0.92, 0.98) were significantly associated with a diminished risk of hip fracture (Table 4).
The age of the patients with hip fractures (Cohen’s d 0.63; 95% CI 0.44, 0.82) was significantly higher than the non-fracture group. However, the hip fracture patients’ weight (Cohen’s d −0.23; 95% CI −0.3, −0.15) and BMI (Cohen’s d −0.29; 95% CI −0.37, −0.21) were significantly lower than the non-fracture group. Age at menopause (Cohen’s d −0.14; 95% CI −0.29, 0.02) and height (Cohen’s d 0; 95% CI −0.13, 0.13) were not significantly different between the two groups (Table 5).

4. Discussion

Although prior studies have described hip fracture risk associated with individual demographic factors, this is the first comprehensive review that includes multiple significant sociodemographic and lifestyle risk factors reported across various studies. This study represents extensive data from 69 papers with a cohort of 976,677 participants and 99,298 cases of hip fractures. Our meta-analysis evaluated diverse demographic features to report pooled odds ratios for hip fracture development. Among the examined factors, menopause (OR 7.21), residing in a residential care facility (OR 5.30), and having a history of previous fracture (OR 3.16) displayed the highest significant associations with hip fractures. Additionally, age over 85 years, female sex, underweight status, a family history of maternal hip fracture, being single and unmarried, living alone, and having a history of falls were all positively and significantly associated with an increased risk of hip fractures.
Conversely, significant protective factors against hip fractures included being overweight or obese, parity, Asian, Black, Hispanic, or non-Caucasian ethnicity, and residing in a rural area. A review of the molecular underpinnings of osteoporosis by Zhivodernikov et al. discusses important factors such as estrogen deficiency, inflammation, oxidative stress, cellular senescence, and genetic and epigenetic factors that mechanistically contribute to an imbalance in the remodeling process, leading to bone resorption and osteoporosis [75]. Our findings contribute valuable new insights to the current understanding of hip fracture risks, emphasizing the importance of considering individual sociodemographic profiles. This knowledge could be instrumental in suggesting modifications to established tools such as FRAX, leading to more personalized and effective prevention strategies for hip fractures.

4.1. Age

Studies have consistently demonstrated a positive correlation between increased age, elevated osteopontin (OPN) levels, and a decreased BMD index [76,77]. Furthermore, advanced age is linked to hormonal changes, notably a decline in women’s estrogen levels, reduced muscle mass and strength, and impaired balance and coordination [67,78]. These factors collectively contribute to an increased risk of falls and subsequent hip fractures. A total of 29 out of the 34 studies that reported the mean age of both the hip fracture and non-fracture groups indicated significantly higher ages within the fracture group (pooled Cohen’s d 0.63; 95% CI 0.44 to 0.82; p < 0.01) [6,10,18,19,20,21,22,23,24,29,32,33,34,36,39,41,43,44,47,48,49,50,52,53,57,59,60,61,62,63,65,69,71,74] (Figure 2). This finding aligns with earlier research highlighting decreased BMD with advancing age and heightened susceptibility to fractures among older, more vulnerable groups.
Although a previous study by Turner et al. [64] delineated age over 65 as a threshold associated with significantly higher hip fracture risk, recent publications by Al-algawy et al. [11] and Lin et al. [42] did not observe a significant association between the age 65 and hip fracture; the pooled data from the current meta-analysis further confirms this, revealing that age over 65 is not significantly associated with hip fractures (pooled OR 1.66; 95% CI 0.40 to 6.96; p = 0.49) [11,42,64]. Notably, an intriguing pattern emerged when analyzing recent studies. Pooled data from these studies consistently indicate a significant association between age over 85 and hip fractures (pooled OR 1.75; 95% CI 1.28 to 2.38; p < 0.01) [32,38,66] (Figure 3).

4.2. Sex

The increased risk of hip fracture among the female population is among the most well-understood demographic risk factors for hip fracture [6,20,27,38,43,47,48,52] (Figure 4). The decline in estrogen in post-menopausal women has been known to result in a progressive loss of BMD and a consequent elevated fracture risk [6]. In addition to this well-known explanation for the higher risk of hip fractures among women, several studies report associations between other variables and the female sex [33,79]. For example, falls are higher among women than men [79]. Similarly, studies show a stronger association between age and hip fracture risk among women than men [22]. In addition, diabetes is correlated with increased fall risk and hip fracture risk. This correlation is particularly strong for post-menopausal women due to a decline in BMD [33].

4.3. Menopause

Studies were evaluated for the bivariate menopausal status as a risk factor for hip fracture outcomes among the female population. The decline in estrogen levels during menopause is a key factor influencing the risk of hip fracture. Estrogen is crucial in maintaining bone density and strength by regulating the balance between bone formation and resorption [80]. As estrogen levels decrease, this balance tilts toward bone resorption, gradually reducing bone mass and integrity. The pooled analysis within the current meta-analysis reveals a compelling finding: menopause emerges as the most substantial single risk factor linked to hip fractures (OR 7.21; 95% CI 4.29, 12.12) [20,29] (Figure 5). Interestingly, while menopause plays a pivotal role, the age at which menopause occurs does not appear to differ significantly between the groups of individuals with and without fractures [19,33] (Supplemental Figure S1).

4.4. Caucasian Ancestry

Ancestry has long been associated with the risk of hip fracture. Our combined analysis is consistent with prior studies that report a higher risk of hip fracture for white individuals than non-white individuals of Asian, Hispanic, or Black ancestry [10,25,37,54,61,64,66,68,71] (Figure 6). Some potential contributions to differences in relative risk include differences in genetic determinants of BMD, differences in hip morphology, differences in bone remodeling capacity, and lifestyle factors such as diet and nutrition [37]. With the global surge in osteoporotic hip fractures, it becomes imperative to enhance tools like FRAX to incorporate ancestry-based distinctions, particularly within under-represented ethnic communities. In addition, the growing diversity of the patient population in the United States justifies the need for further investigation into the underlying mediators between ancestry and the risk of hip fracture.

4.5. BMI

The literature suggests that an increased BMI is protective against hip fractures. A lower BMI is associated with increased hip fracture occurrence. Conversely, a higher BMI is associated with a decreased hip fracture rate [81]. Studies also show a relationship between BMI and BMD, where higher BMD levels are associated with a higher BMI, partly explaining the protectiveness of BMI for hip fracture [82]. Similarly, our data show that being underweight (OR 1.72; 95% CI 1.35, 2.18; p < 0.01) [17,31,33,47,64,68] poses a significantly higher risk for fracture, while being overweight (OR 0.59; 95% CI 0.45, 0.77; p < 0.01) [17,33,47,52,64,68] and being obese (OR 0.38; 95% CI 0.18, 0.77; p < 0.01) [47,52,64,68] result in a significantly lower risk for fracture (Figure 7). Further data show hip fracture patients to have a lower BMI compared to patients with no hip fracture (pooled Cohen’s d −0.29; 95% CI −0.37 to −0.21; p < 0.01) [8,10,15,17,18,19,20,28,29,30,35,39,41,44,46,47,48,60,61,62,63,65,67,71,74] (Supplemental Figure S2). BMI-associated findings are explained in relation to fatty tissue. Fat tissue provides cushioning and protects bones from impact, while peripheral fat is considered protective as it is an endogenous source of estrogen [81]. Being underweight can lead to osteoporosis, potentially due to decreased sources of estrogen [83].

4.6. Parity

In our pooled analysis, bearing children was modestly associated with a decreased risk of hip fracture (OR 0.79; 95% CI 0.69, 0.92; p < 0.01) (Figure 8). Research regarding fracture risk and parity has been conflicting, and our analysis is consistent with most studies that report an association between nulliparity and elevated hip fracture risk [8,29,54]. Although the exact mechanism is poorly understood, this association is believed to result from a hormonal environment that impedes pregnancy and bone formation [54]. Paradoxically, while some studies report that high parity is associated with a reduced risk of hip fracture, others report that multiparity is associated with a higher risk of hip fracture [4,33]. Thus, it remains unclear whether childbearing is truly protective against hip fractures.

4.7. Marital Status

In addition to parity, marital status has been reported as a protective factor against hip fractures [6,24] (Supplemental Figure S3). Potential mechanisms for this beneficial effect include healthier lifestyle behaviors such as a more dynamic social life, a better diet, less need for medication, and more physical activity. In contrast, divorced, widowed, or single unmarried individuals may lead less active lifestyles and are possibly at higher risk of depressive disorders [22]. Similarly, among women who never married, those who lived alone reported higher rates of hip fractures than those who lived with another person [26,54]. Interestingly, Farahmand et al. [8] report that the association between marital status and hip fracture risk is stronger later in life than earlier.
Further, nursing home occupancy was shown to be more common in unmarried individuals, which may explain the stronger correlation between hip fracture and marital status in older adults [8]. Ultimately, this association must be interpreted cautiously since the lack of a partner may be confounded with old age. Nevertheless, marital status presents an intriguing avenue to explore the link between psychosocial well-being and morbidity in the elderly population.

4.8. Environmental Factors

Although less studied, living in a residential care facility was the second highest risk factor significantly associated with the risk of hip fracture in our pooled analysis (OR 5.30; 95% CI 1.91, 14.75) (Figure 9). Since the average age of residents in these facilities is often higher than that of individuals living independently, component studies implemented community matching to address potential confounders. One possible mechanism for this association between hip fracture risk and residential facilities is that institutionalized individuals experience low activity levels and impaired mobility. This results in poor bone mass and a higher risk of injury than community-matched peers [79]. Since individuals in residential care settings have limited outdoor exposure, vitamin D3 supplementation, and hip protectors have been implemented as protective measures against hip fractures [63,84].
Nevertheless, institutionalization has been shown to predispose occupants of residential care facilities to this injury [79,85]. Additionally, living alone has consistently been linked to a heightened risk of hip fractures (OR 1.47; 95% CI 1.15, 1.89). This correlation could be attributed to the lack of a spouse or family members in the immediate vicinity [48,73]. The absence of a support system can render these individuals more vulnerable to the consequences of accidents, particularly falls that result in hip fractures. This emphasizes the pressing need for intensified medical and healthcare personnel attention to strengthen prevention and education efforts for this vulnerable group.
The lower hip fracture rates observed in rural areas can be attributed to factors promoting better bone health and reduced fall risks [11,22,26]. Rural residents frequently engage in physically demanding activities, fostering muscle strength and physical fitness. Furthermore, traditional diets rich in fresh produce provide essential nutrients for strong bones. Although rural residence was associated with a significantly lower hip fracture risk, the odds ratio representing this association was only minimally lower (OR 0.95; 95% CI 0.92, 0.98).

4.9. Previous Falls

Falls represent the principal mechanism of injury in hip fractures [12]. For this reason, a history of falls puts patients at a greater risk of experiencing fractures (OR 1.88; 95% CI 1.43, 2.47) (Figure 10). Although skeletal factors such as BMD pose more significant risks to patients under the age of 80, the risk of falling becomes more concerning in older individuals [14]. Fall risk increases exponentially over the age of 80 due to increases in visual impairments, lower extremity neuropathies, and progressive muscle weakness [33]. Furthermore, some studies report that the direction and manner in which patients fall are essential to determining hip fracture risk [33,85]. In typical patients, it has been reported that a sideways fall increases the risk of hip fracture up to five-fold [85]. Changing the fall direction has been mentioned as a method for preventing hip fractures to avoid such unfavorable odds. Despite this evidence, not all studies have confirmed this association [14]. Further investigation is required to evaluate whether risk assessment tools that account for the history and direction of falls are more predictive of hip fracture risk than those that do not.

4.10. Previous Fractures

A history of previous fractures has been associated with an increased risk of future hip and spine injury, especially among older adults [6]. For this reason, fracture risk prediction models have considered prior fractures when evaluating individuals at risk. One such model is the Fracture and Mortality Index (FRAMO), based on four risk factors (age above 80 years, weight lower than 60 kg, prior fracture, and the need to use arms to rise) [12]. This model reports a significantly elevated fracture risk for women with previous fractures. A commonly accepted mechanism for this risk factor is that patients experiencing more frequent fractures have markedly lower global BMD. Spine BMD and a history of vertebral fractures are moderate predictors of hip fracture risk [85]. In this meta-analysis, a history of prior fractures had the third highest association with future hip fractures among all risk factors studied (OR 3.16; 95% CI 2.08, 4.80) (Figure 10). This is consistent with most studies, which report that previous fractures are among the strongest risk factors for future hip injury [6,14,17,29,40,41,42,46,54,61,67,68,86]. However, some studies report that a history of prior falls is more useful as a predictor of hip fracture for patients older than 80 years, while a history of prior fractures is a superior marker for those under 80 [14]. Further investigation is needed to make more definitive conclusions regarding the utility of previous fractures as a predictor of future hip fractures across age groups. While previous falls and fractures are correlated variables, we cannot draw conclusions based on the available data for all fall-associated fractures or types of falls that lead to higher fracture rates.

4.11. Family History of Hip Fracture and Osteoporosis

Prior studies have indicated a significant correlation between an individual’s risk of hip fracture and the incidence of hip fractures among their parents [14,54,68]. This association is based on higher correlations between the bone densities of twins compared to other nuclear family members. Moreover, genetic factors contribute to the rapid decline in BMD in post-menopausal women [14]. For this reason, some studies have placed a special focus on maternal history of hip fracture when evaluating an individual’s fracture risk. However, recent studies have shown a more nuanced relationship between hip fracture risk and family history of hip fracture. These studies report that at a younger age, a patient’s parental hip fracture history is more of a determinant for fracture risk and less so as they age [14,24]. In older patients, falling is a much more significant risk factor. There is disagreement over the age at which the family history of hip fractures is no longer significant. One study reports that family history remains a strong predictor for patients until age 80 [14]. In contrast, another report states that family history is no longer significantly associated with hip fracture risk after age 50 [24]. Our pooled analysis shows a statistically significant correlation between hip fracture risk and family history. However, further study is warranted to determine the relationship between age and the predictive strength of family history (Supplemental Figure S4).

4.12. Fracture Risk Assessment

The FRAX, or Fracture Risk Assessment tool, was developed by the World Health Organization to calculate the risk of fractures more accurately, with or without factoring in BMD. Among the demographic risk factors elucidated earlier, FRAX encompasses solely sex, a history of fractures, and familial fracture history [7]. Our study highlights a range of sociodemographic risk factors that are significantly connected to the risk of hip fractures. This emphasis seeks to pave the way for more refined future models to enhance accuracy.

4.13. Limitations

Common limitations of meta-analyses include statistical heterogeneity and the quality of the papers included. The included studies were assessed using the Newcastle–Ottawa Scale, which found them all high quality. Although we prioritized data from multivariate analyses, it is possible that some confounders may not have been addressed in some of the original studies. Regarding marital status as a demographic risk factor for hip fractures, a potential confounder could be old age since widowed individuals tend to be among older adults, with an inherently higher risk of hip fracture. Additionally, since this study synthesized data from observational studies, a causal inference cannot be drawn. While we did not explore the treatment options available for osteoporosis, identifying populations at risk can help us direct patient care through preventative care metrics such as nutritional care, lifestyle modifications, hormone therapy, and new emerging tools such as whole-body vibration, which has the potential to increase bone mass and density [9,87,88]. Nonetheless, exploring the literature allows for a holistic evaluation of the gaps in the current understanding and draws attention to areas of future study.

5. Conclusions

This is a large-scale meta-analysis of 976,677 participants and 99,298 hip fractures for a comprehensive review of sociodemographic factors. The data presented in this study indicate that being married, parity, BMI > 25, non-Caucasian descent, and rural residence diminish the risk of hip fracture. In contrast, age > 85, BMI < 18.5, female sex, previous falls, previous fractures, menopause, history of maternal hip fracture, being single and unmarried, being divorced, living in a residential care facility, and living alone are associated with elevated hip fracture risk. As such, healthcare providers should consider preventative measures for individuals at a higher risk of hip fracture based on these categories.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/osteology4020006/s1, Figure S1. Forest plot demonstrating pooled effect size of age at menopause as a risk factor for osteoporotic hip fracture. Figure S2. Forest plot demonstrating pooled effect size of BMI as a risk factor for osteoporotic hip fracture. Figure S3. Forest plot demonstrating pooled odds ratio of marital status as a risk factor for osteoporotic hip fracture. Figure S4. Forest plot demonstrating pooled odds ratio of family history of osteoporosis or hip fracture as a risk factor for osteoporotic hip fracture. Figure S5. Funnel plot for pooled effect size of age as a risk factor for osteoporotic hip fracture. Figure S6. Funnel plot for pooled odds ratio of age as a risk factor for osteoporotic hip fracture. Figure S7. Funnel plot for a pooled odds ratio of sex as a risk factor for osteoporotic hip fracture. Figure S8. Funnel plot for a pooled odds ratio of menopause status as a risk factor for osteoporotic hip fracture. Figure S9. Funnel plot for pooled effect size of age at menopause as a risk factor for osteoporotic hip fracture. Figure S10. Funnel plot for a pooled odds ratio of ancestry as a risk factor for osteoporotic hip fracture. Figure S11. Funnel plot for a pooled odds ratio of BMI as a risk factor for osteoporotic hip fracture. Figure S12. Funnel plot for the pooled effect size of BMI as a risk factor for osteoporotic hip fracture. Figure S13. Funnel plot for pooled odds ratio of parity status as a risk factor for osteoporotic hip fracture. Figure S14. Funnel plot for pooled odds ratio of marital status as a risk factor for osteoporotic hip fracture. Figure S15. Funnel plot for pooled odds ratio of residential status as a risk factor for osteoporotic hip fracture. Figure S16. Funnel plot for pooled odds ratio of history of falling and fractures as risk factors for osteoporotic hip fracture. Figure S17. Funnel plot for pooled odds ratio of family history of osteoporosis or hip fracture as a risk factor for osteoporotic hip fracture.

Author Contributions

Conceptualization, A.N., A.v.K., J.J.W., and P.A.; methodology, D.Y., K.M., A.M., S.J.M., I.R.B., D.C., N.K., M.M., J.J.W., and P.A.; formal analysis, D.Y., K.M., A.M., S.J.M., I.R.B., D.C., N.K., M.M., J.J.W., and P.A.; resources, A.N. and A.v.K.; writing—original draft preparation, D.Y., and K.M.; writing—review and editing, D.Y., K.M., A.M., S.J.M., I.R.B., D.C., N.K., M.M., J.J.W., P.A., A.v.K., and A.N.; visualization, D.Y., and K.M.; supervision, A.N.; project administration, A.N. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

All data generated or analyzed during this study are included in this published article [and its supplementary information files].

Conflicts of Interest

The authors declare no conflicts of interest.

Appendix A

MEDLINE (Ovid) Search Strategy
Ovid MEDLINE(R) Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily, Ovid MEDLINE and Versions(R)
(((exp hip fractures/OR ((hip OR hips) adj3 fracture*).ab,ti) AND (exp osteoporosis/OR osteoporo*.ab,ti)) OR ((exp osteoporotic fractures/OR (osteoporo* adj3 fracture*).ab,ti OR fragility fracture*.ab,ti) AND (exp hip/OR exp hip joint/OR hip.ab,ti OR hips.ab,ti)))
AND
exp risk/OR exp odds ratio/OR (risk OR odds ratio OR hazard ratio).ab,ti
PubMed Search Strategy
Years: 2017 to January 2022
(“Hip Fractures”[MeSH] OR (“Hip”[tiab] AND “Fracture*” [tiab]) OR “Hip”[MeSH] OR (“Hips”[tiab] AND “Fracture*”[tiab]) AND (“Osteoporosis”[tiab] OR “Osteoporosis”[MeSH] OR “Osteoporotic Fractures”[tiab] OR (“Osteoporo*”[tiab] AND “Fracture*”[tiab]) OR “Fragility Fracture*”[tiab]) AND (“Hip Joint”[MeSH] OR “Hip”[MeSH] OR “Hip”[tiab] OR “Hips”[tiab]) AND (“Risk”[MeSH] OR “Odds Ratio”[MeSH] OR “Risk”[tiab] OR “Odds Ratio”[tiab] OR “Hazard Ratio”[tiab])

References

  1. Fisher, E.S.; Baron, J.A.; Malenka, D.J.; Barrett, J.A.; Kniffin, W.D.; Whaley, F.S.; Bubolz, T.A. Hip fracture incidence and mortality in New England. Epidemiology 1991, 2, 116–122. [Google Scholar] [CrossRef] [PubMed]
  2. Hippisley-Cox, J.; Coupland, C. Derivation and validation of updated QFracture algorithm to predict the risk of osteoporotic fracture in primary care in the United Kingdom: Prospective open cohort study. BMJ 2012, 344, e3427. [Google Scholar] [CrossRef] [PubMed]
  3. Finsterwald, M.; Sidelnikov, E.; Orav, E.J.; Dawson-Hughes, B.; Theiler, R.; Egli, A.; Platz, A.; Simmen, H.P.; Meier, C.; Grob, D.; et al. Gender-specific hip fracture risk in community-dwelling and institutionalized seniors age 65 years and older. Osteoporos. Int. 2014, 25, 167–176. [Google Scholar] [CrossRef] [PubMed]
  4. Michaelsson, K.; Baron, J.A.; Farahmand, B.Y.; Ljunghall, S. Influence of parity and lactation on hip fracture risk. Am. J. Epidemiol. 2001, 153, 1166–1172. [Google Scholar] [CrossRef] [PubMed]
  5. Espino, D.V.; Silva Ross, J.; Oakes, S.L.; Becho, J.; Wood, R.C. Characteristics of hip fractures among hospitalized elder Mexican American Black and White Medicare beneficiaries in the Southwestern United States. Aging Clin. Exp. Res. 2008, 20, 344–348. [Google Scholar] [CrossRef] [PubMed]
  6. Albaba, M.; Cha, S.S.; Takahashi, P.Y. The Elders Risk Assessment Index, an electronic administrative database-derived frailty index, can identify the risk of hip fracture in a cohort of community-dwelling adults. Mayo Clin. Proc. 2012, 87, 652–658. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  7. FitzGerald, G.; Compston, J.E.; Chapurlat, R.D.; Pfeilschifter, J.; Cooper, C.; Hosmer, D.W., Jr.; Adachi, J.D.; Anderson, F.A., Jr.; Diez-Perez, A.; Greenspan, S.L.; et al. Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW). J. Clin. Endocrinol. Metab. 2014, 99, 817–826. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  8. Farahmand, B.Y.; Persson, P.G.; Michaelsson, K.; Baron, J.A.; Parker, M.G.; Ljunghall, S.; Swedish hip fracture, g. Socioeconomic status, marital status, and hip fracture risk: A population-based case-control study. Osteoporos. Int. 2000, 11, 803–808. [Google Scholar] [CrossRef] [PubMed]
  9. Mortensen, S.J.; Beeram, I.; Florance, J.; Momenzadeh, K.; Mohamadi, A.; Rodriguez, E.K.; von Keudell, A.; Nazarian, A. Modifiable lifestyle factors associated with fragility hip fracture: A systematic review and meta-analysis. J. Bone Min. Metab. 2021, 39, 893–902. [Google Scholar] [CrossRef] [PubMed]
  10. Adams, A.L.; Fischer, H.; Kopperdahl, D.L.; Lee, D.C.; Black, D.M.; Bouxsein, M.L.; Fatemi, S.; Khosla, S.; Orwoll, E.S.; Siris, E.S.; et al. Osteoporosis and Hip Fracture Risk From Routine Computed Tomography Scans: The Fracture, Osteoporosis, and CT Utilization Study (FOCUS). J. Bone Miner. Res. 2018, 33, 1291–1301. [Google Scholar] [CrossRef]
  11. Al-Algawy, A.A.H.; Baiee, H.A.; Hasan, S.; Jassim, I.; Razaq, M.; Kamel, F.; Ali, A.; Khudhair, E. Risk Factors Associated with Hip Fractures among Adult People in Babylon City, Iraq. Open Access Maced. J. Med. Sci. 2019, 7, 3608–3614. [Google Scholar] [CrossRef] [PubMed]
  12. Albertsson, D.; Mellstrom, D.; Petersson, C.; Thulesius, H.; Eggertsen, R. Hip and fragility fracture prediction by 4-item clinical risk score and mobile heel BMD: A women cohort study. BMC Musculoskelet. Disord. 2010, 11, 55. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  13. Anastasilakis, A.D.; Polyzos, S.A.; Kitridis, D.; Makras, P.; Yavropoulou, M.P.; Palermo, A.; Gerou, S.; Ntenti, C.; Ballaouri, I.; Savvidis, M. Ιrisin levels in postmenopausal women with an incident hip fracture. Endocrine 2021, 73, 719–722. [Google Scholar] [CrossRef] [PubMed]
  14. Anpalahan, M.; Morrison, S.G.; Gibson, S.J. Hip fracture risk factors and the discriminability of hip fracture risk vary by age: A case-control study. Geriatr. Gerontol. Int. 2014, 14, 413–419. [Google Scholar] [CrossRef] [PubMed]
  15. Ardiansyah, A.; Yuwana, S. Anthropometric measurements associated with intertrochanteric fractures in the elderly: A case-control study. Med. J. Indones. 2019, 28, 365–369. [Google Scholar] [CrossRef]
  16. Bartels, S.; Gjertsen, J.-E.; Frihagen, F.; Rogmark, C.; Utvag, S.E. Low bone density and high morbidity in patients between 55 and 70 years with displaced femoral neck fractures: A case-control study of 50 patients vs 150 normal controls. BMC Musculoskelet. Disord. 2019, 20, 371. [Google Scholar] [CrossRef]
  17. de Bruin, I.J.A.; Wyers, C.E.; Souverein, P.C.; van Staa, T.P.; Geusens, P.P.M.M.; van den Bergh, J.P.W.; de Vries, F.; Driessen, J.H.M. The risk of new fragility fractures in patients with chronic kidney disease and hip fracture-a population-based cohort study in the UK. Osteoporos. Int. 2020, 31, 1487–1497. [Google Scholar] [CrossRef]
  18. Chang, C.-B.; Yang, R.-S.; Chang, L.-Y.; Peng, J.-K.; Tsar, K.-S.; Huang, W.-J.; Yang, T.-H.; Chan, D.-C. Fracture types affect clinical outcomes of patients managed within the fracture liaison and osteoporosis medication management services. Sci. Rep. 2019, 9, 10089. [Google Scholar] [CrossRef]
  19. Chen, F.P.; Fu, T.S.; Lin, Y.C.; Fan, C.M. Risk factors and quality of life for the occurrence of hip fracture in postmenopausal women. Biomed. J. 2018, 41, 202–208. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  20. Dai, Z.; Jin, A.; Soh, A.Z.; Ang, L.-W.; Yuan, J.-M.; Koh, W.-P. Coffee and tea drinking in relation to risk of hip fracture in the Singapore Chinese Health Study. Bone 2018, 112, 51–57. [Google Scholar] [CrossRef]
  21. Enns-Bray, W.S.; Bahaloo, H.; Fleps, I.; Pauchard, Y.; Taghizadeh, E.; Sigurdsson, S.; Aspelund, T.; Buechler, P.; Harris, T.; Gudnason, V.; et al. Biofidelic finite element models for accurately classifying hip fracture in a retrospective clinical study of elderly women from the AGES Reykjavik cohort. Bone 2019, 120, 25–37. [Google Scholar] [CrossRef]
  22. Fernandez-Ruiz, M.; Guerra-Vales, J.M.; Trincado, R.; Medrano, M.J.; Benito-Leon, J.; Bermejo-Pareja, F. Hip fracture in three elderly populations of central Spain: Data from the NEDICES study. Intern. Emerg. Med. 2014, 9, 33–41. [Google Scholar] [CrossRef] [PubMed]
  23. Fisher, A.; Srikusalanukul, W.; Fisher, L.; Smith, P.N. Lower serum PINP/beta CTX ratio and hypoalbuminemia are independently associated with osteoporotic nonvertebral fractures in older adults. Clin. Interv. Aging 2017, 12, 1131–1140. [Google Scholar] [CrossRef]
  24. Fox, K.M.; Cummings, S.R.; Williams, E.; Stone, K.; Study of Osteoporotic, F. Femoral neck and intertrochanteric fractures have different risk factors: A prospective study. Osteoporos. Int. 2000, 11, 1018–1023. [Google Scholar] [CrossRef] [PubMed]
  25. Grisso, J.A.; Kelsey, J.L.; O’Brien, L.A.; Miles, C.G.; Sidney, S.; Maislin, G.; LaPann, K.; Moritz, D.; Peters, B. Risk factors for hip fracture in men. Hip Fracture Study Group. Am. J. Epidemiol. 1997, 145, 786–793. [Google Scholar] [CrossRef] [PubMed]
  26. Hansen, L.; Judge, A.; Javaid, M.K.; Cooper, C.; Vestergaard, P.; Abrahamsen, B.; Harvey, N.C. Social inequality and fracturessecular trends in the Danish population: A case-control study. Osteoporos. Int. 2018, 29, 2243–2250. [Google Scholar] [CrossRef]
  27. Holvik, K.; Meyer, H.E.; Laake, I.; Feskanich, D.; Omsland, T.K.; Sogaard, A.-J. Milk drinking and risk of hip fracture: The Norwegian Epidemiologic Osteoporosis Studies (NOREPOS). Br. J. Nutr. 2019, 121, 709–718. [Google Scholar] [CrossRef]
  28. Hong, N.; Park, H.; Kim, C.O.; Kim, H.C.; Choi, J.-Y.; Kim, H.; Rhee, Y. Bone Radiomics Score Derived from DXA Hip Images Enhances Hip Fracture Prediction in Older Women. J. Bone Miner. Res. 2021, 36, 1708–1716. [Google Scholar] [CrossRef]
  29. Huang, Z.; Himes, J.H.; McGovern, P.G. Nutrition and subsequent hip fracture risk among a national cohort of white women. Am. J. Epidemiol. 1996, 144, 124–134. [Google Scholar] [CrossRef] [PubMed]
  30. Humbert, L.; Bague, A.; Di Gregorio, S.; Winzenrieth, R.; Sevillano, X.; Gonzalez Ballester, M.A.; Del Rio, L. DXA-Based 3D Analysis of the Cortical and Trabecular Bone of Hip Fracture Postmenopausal Women: A Case-Control Study. J. Clin. Densitom. 2020, 23, 403–410. [Google Scholar] [CrossRef]
  31. Hundrup, Y.A.; Ekholm, O.; Hoidrup, S.; Davidsen, M.; Obel, E.B. Risk factors for hip fracture and a possible effect modification by hormone replacement therapy. The Danish nurse cohort study. Eur. J. Epidemiol. 2005, 20, 871–877. [Google Scholar] [CrossRef] [PubMed]
  32. Hung, S.-C.; Liao, K.-F.; Hung, H.-C.; Lin, C.-L.; Lee, P.-C.; Hung, S.-J.; Lai, S.-W. Tamoxifen use correlates with increased risk of hip fractures in older women with breast cancer: A case-control study in Taiwan. Geriatr. Gerontol. Int. 2019, 19, 56–60. [Google Scholar] [CrossRef]
  33. Hwang, H.F.; Lee, H.D.; Huang, H.H.; Chen, C.Y.; Lin, M.R. Fall mechanisms, bone strength, and hip fractures in elderly men and women in Taiwan. Osteoporos. Int. 2011, 22, 2385–2393. [Google Scholar] [CrossRef] [PubMed]
  34. Iki, M.; Winzenrieth, R.; Tamaki, J.; Sato, Y.; Dongmei, N.; Kajita, E.; Kouda, K.; Yura, A.; Tachiki, T.; Kamiya, K.; et al. Predictive ability of novel volumetric and geometric indices derived from dual-energy X-ray absorptiometric images of the proximal femur for hip fracture compared with conventional areal bone mineral density: The Japanese Population-based Osteoporosis (JPOS) Cohort Study. Osteoporos. Int. 2021, 32, 2289–2299. [Google Scholar] [CrossRef]
  35. Jha, R.M.; Mithal, A.; Malhotra, N.; Brown, E.M. Pilot case-control investigation of risk factors for hip fractures in the urban Indian population. BMC Musculoskelet. Disord. 2010, 11, 49. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  36. Kauppi, M.; Stenholm, S.; Impivaara, O.; Maki, J.; Heliovaara, M.; Jula, A. Fall-related risk factors and heel quantitative ultrasound in the assessment of hip fracture risk: A 10-year follow-up of a nationally representative adult population sample. Osteoporos. Int. 2014, 25, 1685–1695. [Google Scholar] [CrossRef] [PubMed]
  37. Khandelwal, S.; Chandra, M.; Lo, J.C. Clinical characteristics, bone mineral density and non-vertebral osteoporotic fracture outcomes among post-menopausal U.S. South Asian Women. Bone 2012, 51, 1025–1028. [Google Scholar] [CrossRef] [PubMed]
  38. Kim, J.; Jang, S.-N.; Lim, J.-Y. Pre-Existing Disability and Its Risk of Fragility Hip Fracture in Older Adults. Int. J. Environ. Res. Public Health 2019, 16, 1237. [Google Scholar] [CrossRef]
  39. Komorita, Y.; Iwase, M.; Idewaki, Y.; Fujii, H.; Ohkuma, T.; Ide, H.; Jodai-Kitamura, T.; Yoshinari, M.; Murao-Kimura, A.; Oku, Y.; et al. Impact of hip fracture on all-cause mortality in Japanese patients with type 2 diabetes mellitus: The Fukuoka Diabetes Registry. J. Diabetes Investig. 2020, 11, 62–69. [Google Scholar] [CrossRef]
  40. Lam, M.-T.; Sing, C.-W.; Li, G.H.Y.; Kung, A.W.C.; Tan, K.C.B.; Cheung, C.-L. Development and Validation of a Risk Score to Predict the First Hip Fracture in the Oldest Old: A Retrospective Cohort Study. J. Gerontol. Ser. A-Biol. Sci. Med. Sci. 2020, 75, 980–986. [Google Scholar] [CrossRef]
  41. Leslie, W.D.; Lix, L.M.; Majumdar, S.R.; Morin, S.N.; Johansson, H.; Oden, A.; McCloskey, E.V.; Kanis, J.A. Total Hip Bone Area Affects Fracture Prediction with FRAX (R) in Canadian White Women. J. Clin. Endocrinol. Metab. 2017, 102, 4242–4249. [Google Scholar] [CrossRef]
  42. Lin, J.-C.; Liu, Z.-G.; Liu, R.-R.; Xie, L.-W.; Xie, H.-L.; Cai, H.-G. The increase of osteopontin and beta-carboxy-terminal cross-linking telopeptide of type I collagen enhances the risk of hip fracture in the elderly. J. Clin. Lab. Anal. 2020, 34, e23204. [Google Scholar] [CrossRef]
  43. Lin, C.C.; Li, C.I.; Liu, C.S.; Wang, M.C.; Lin, C.H.; Lin, W.Y.; Yang, S.Y.; Li, T.C. Lifetime risks of hip fracture in patients with type 2 diabetic: Taiwan Diabetes Study. Osteoporos. Int. 2021, 32, 2571–2582. [Google Scholar] [CrossRef] [PubMed]
  44. Liu, Z.; Gao, H.; Bai, X.; Zhao, L.; Li, Y.; Wang, B. Evaluation of Singh Index and Osteoporosis Self-Assessment Tool for Asians as risk assessment tools of hip fracture in patients with type 2 diabetes mellitus. J. Orthop. Surg. Res. 2017, 12, 37. [Google Scholar] [CrossRef]
  45. Liu, Y.; Guo, Y.-L.; Meng, S.; Gao, H.; Sui, L.-J.; Jin, S.; Li, Y.; Fan, S.-G. Gut microbiota-dependent Trimethylamine N-Oxide are related with hip fracture in postmenopausal women: A matched case-control study. Aging-Us 2020, 12, 10633–10641. [Google Scholar] [CrossRef]
  46. Liu, Z.M.; Huang, Q.; Li, S.Y.; Liu, Y.P.; Wu, Y.; Zhang, S.J.; Li, B.L.; Chen, Y.M. A 1:1 matched case-control study on dietary protein intakes and hip fracture risk in Chinese elderly men and women. Osteoporos. Int. 2021, 32, 2205–2216. [Google Scholar] [CrossRef] [PubMed]
  47. Lobo, E.; Marcos, G.; Santabarbara, J.; Salvador-Roses, H.; Lobo-Escolar, L.; De la Camara, C.; Aso, A.; Lobo-Escolar, A.; Zarademp, W. Gender differences in the incidence of and risk factors for hip fracture: A 16-year longitudinal study in a southern European population. Maturitas 2017, 97, 38–43. [Google Scholar] [CrossRef]
  48. Min, D.; Lee, H.S.; Shin, M. Consequences of fall-induced hip fractures on cognitive function, physical activity, and mortality: Korean longitudinal study of aging 2006–2016. Inj.-Int. J. Care Inj. 2021, 52, 933–940. [Google Scholar] [CrossRef]
  49. Muehlberg, A.; Museyko, O.; Bousson, V.; Pottecher, P.; Laredo, J.-D.; Engelke, K. Three-dimensional Distribution of Muscle and Adipose Tissue of the Thigh at CT: Association with Acute Hip Fracture. Radiology 2019, 290, 426–434. [Google Scholar] [CrossRef]
  50. Nakatoh, S.; Fujimori, K.; Tamaki, J.; Okimoto, N.; Ogawa, S.; Iki, M. Insufficient persistence of and adherence to osteoporosis pharmacotherapy in Japan. J. Bone Miner. Metab. 2021, 39, 501–509. [Google Scholar] [CrossRef]
  51. Papadimitriou, N.; Tsilidis, K.K.; Orfanos, P.; Benetou, V.; Ntzani, E.E.; Soerjomataram, I.; Kuenn-Nelen, A.; Pettersson-Kymmer, U.; Eriksson, S.; Brenner, H.; et al. Burden of hip fracture using disability-adjusted life-years: A pooled analysis of prospective cohorts in the CHANCES consortium. Lancet Public Health 2017, 2, E239–E246. [Google Scholar] [CrossRef]
  52. Ramirez-Martin, R.; Castell Alcala, M.V.; Alarcon, T.; Queipo, R.; Rios German, P.P.; Otero Puime, A.; Ignacio Gonzalez-Montalvo, J. Comprehensive geriatric assessment for identifying older people at risk of hip fracture: Cross-sectional study with comparative group. Fam. Pract. 2017, 34, 679–684. [Google Scholar] [CrossRef]
  53. Robbins, J.A.; Schott, A.M.; Garnero, P.; Delmas, P.D.; Hans, D.; Meunier, P.J. Risk factors for hip fracture in women with high BMD: EPIDOS study. Osteoporos. Int. 2005, 16, 149–154. [Google Scholar] [CrossRef] [PubMed]
  54. Robbins, J.; Aragaki, A.K.; Kooperberg, C.; Watts, N.; Wactawski-Wende, J.; Jackson, R.D.; LeBoff, M.S.; Lewis, C.E.; Chen, Z.; Stefanick, M.L.; et al. Factors associated with 5-year risk of hip fracture in postmenopausal women. JAMA 2007, 298, 2389–2398. [Google Scholar] [CrossRef] [PubMed]
  55. Ruiz Wills, C.; Luis Olivares, A.; Tassani, S.; Ceresa, M.; Zimmer, V.; Gonzalez Ballester, M.A.; Miguel del Rio, L.; Humbert, L.; Noailly, J. 3D patient-specific finite element models of the proximal femur based on DXA towards the classification of fracture and non-fracture cases. Bone 2019, 121, 89–99. [Google Scholar] [CrossRef]
  56. Saribal, D.; Hocaoglu-Emre, F.S.; Erdogan, S.; Bahtiyar, N.; Okur, S.C.; Mert, M. Inflammatory cytokines IL-6 and TNF- in patients with hip fracture. Osteoporos. Int. 2019, 30, 1025–1031. [Google Scholar] [CrossRef]
  57. Sarvi, M.N.; Luo, Y. Improving the prediction of sideways fall-induced impact force for women by developing a female-specific equation. J. Biomech. 2019, 88, 64–71. [Google Scholar] [CrossRef]
  58. Shalev, V.; Moser, S.S.; Goldshtein, I.; Yu, J.; Weil, C.; Ish-Shalom, S.; Rouach, V.; Chodick, G. Adherence with Bisphosphonates and Long-Term Risk of Hip Fractures: A Nested Case-Control Study Using Real-World Data. Ann. Pharmacother. 2017, 51, 757–767. [Google Scholar] [CrossRef]
  59. Sharifi, M.D.; Mohebbi, M.; Farrokhfar, M.; Farzaneh, R.; Disfani, H.F.; Hashemian, A.M. Analysis of correlation between estradiol and fracture of femur neck. Eur. J. Transl. Myol. 2018, 28, 214–219. [Google Scholar] [CrossRef]
  60. Su, Y.; Leung, J.; Hans, D.; Aubry-Rozier, B.; Kwok, T. Added clinical use of trabecular bone score to BMD for major osteoporotic fracture prediction in older Chinese people: The Mr. OS and Ms. OS cohort study in Hong Kong. Osteoporos. Int. 2017, 28, 151–160. [Google Scholar] [CrossRef]
  61. Su, Y.; Kwok, T.C.Y.; Cummings, S.R.; Yip, B.H.K.; Cawthon, P.M. Can Classification and Regression Tree Analysis Help Identify Clinically Meaningful Risk Groups for Hip Fracture Prediction in Older American Men (The MrOS Cohort Study)? JBMR Plus 2019, 3, e10207. [Google Scholar] [CrossRef] [PubMed]
  62. Takeshima, K.; Nishiwaki, Y.; Suda, Y.; Niki, Y.; Sato, Y.; Kobayashi, T.; Miyamoto, K.; Uchida, H.; Inokuchi, W.; Tsuji, T.; et al. A missense single nucleotide polymorphism in the ALDH2 gene, rs671, is associated with hip fracture. Sci. Rep. 2017, 7, 428. [Google Scholar] [CrossRef]
  63. Torbergsen, A.C.; Watne, L.O.; Wyller, T.B.; Frihagen, F.; Stromsoe, K.; Bohmer, T.; Mowe, M. Micronutrients and the risk of hip fracture: Case-control study. Clin. Nutr. 2017, 36, 438–443. [Google Scholar] [CrossRef]
  64. Turner, L.W.; Wang, M.Q.; Fu, Q. Risk factors for hip fracture among southern older women. South. Med. J. 1998, 91, 533–540. [Google Scholar] [CrossRef] [PubMed]
  65. Valentini, A.; Federici, M.; Cianfarani, M.A.; Tarantino, U.; Bertoli, A. Frailty and nutritional status in older people: The Mini Nutritional Assessment as a screening tool for the identification of frail subjects. Clin. Interv. Aging 2018, 13, 1237–1244. [Google Scholar] [CrossRef]
  66. Van Den Eeden, S.K.; Barzilay, J.I.; Ettinger, B.; Minkoff, J. Thyroid hormone use and the risk of hip fracture in women > or = 65 years: A case-control study. J. Women’s Health 2003, 12, 27–31. [Google Scholar] [CrossRef] [PubMed]
  67. Wainwright, S.A.; Marshall, L.M.; Ensrud, K.E.; Cauley, J.A.; Black, D.M.; Hillier, T.A.; Hochberg, M.C.; Vogt, M.T.; Orwoll, E.S.; Study of Osteoporotic Fractures Research, G. Hip fracture in women without osteoporosis. J. Clin. Endocrinol. Metab. 2005, 90, 2787–2793. [Google Scholar] [CrossRef] [PubMed]
  68. Weber Silva, D.M.; Cochenski Borba, V.Z.; Kanis, J.A. Evaluation of clinical risk factors for osteoporosis and applicability of the FRAX tool in Joinville City, Southern Brazil. Arch. Osteoporos. 2017, 12, 111. [Google Scholar] [CrossRef]
  69. Wickramarachchi, L.; Peters, J.; Thakrar, A.; Wong, J.M.L.; Mazis, G.; Beckles, V.; Lacey, S.; Chin, K. A dual-site trauma system during COVID-19 pandemic—Our experience in a high-risk area with 60-day mortality report. J. Orthop. 2021, 24, 42–46. [Google Scholar] [CrossRef]
  70. Yang, L.; Parimi, N.; Orwoll, E.S.; Black, D.M.; Schousboe, J.T.; Eastell, R.; Osteoporotic Fractures Men Mro, S. Association of incident hip fracture with the estimated femoral strength by finite element analysis of DXA scans in the Osteoporotic Fractures in Men (MrOS) study. Osteoporos. Int. 2018, 29, 643–651. [Google Scholar] [CrossRef]
  71. Yu, Y.-H.; Cheung, W.S.; Miller, D.R.; Steffensen, B. Number of teeth is associated with hip fracture and femoral neck bone mineral density in the NHANES. Arch. Osteoporos. 2021, 16, 105. [Google Scholar] [CrossRef]
  72. Zhang, Z.-Q.; Cao, W.-T.; Shivappa, N.; Hebert, J.R.; Li, B.-L.; He, J.; Tang, X.-Y.; Liang, Y.-Y.; Chen, Y.-M. Association between Diet Inflammatory Index and Osteoporotic Hip Fracture in Elderly Chinese Population. J. Am. Med. Dir. Assoc. 2017, 18, 671–677. [Google Scholar] [CrossRef]
  73. Zhang, Y.-W.; Lu, P.-P.; Li, Y.-J.; Dai, G.-C.; Chen, M.-H.; Zhao, Y.-K.; Cao, M.-M.; Rui, Y.-F. Prevalence, Characteristics, and Associated Risk Factors of the Elderly with Hip Fractures: A Cross-Sectional Analysis of NHANES 2005–2010. Clin. Interv. Aging 2021, 16, 177–185. [Google Scholar] [CrossRef]
  74. Zhuang, H.-f.; Wang, P.-w.; Li, Y.-z.; Lin, J.-k.; Yao, X.-d.; Xu, H. Analysis of Related Factors of Brittle Hip Fracture in Postmenopausal Women with Osteoporosis. Orthop. Surg. 2020, 12, 194–198. [Google Scholar] [CrossRef]
  75. Zhivodernikov, I.V.; Kirichenko, T.V.; Markina, Y.V.; Postnov, A.Y.; Markin, A.M. Molecular and Cellular Mechanisms of Osteoporosis. Int. J. Mol. Sci. 2023, 24, 15772. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  76. Khosla, S.; Melton, L.J., 3rd; Atkinson, E.J.; O’Fallon, W.M.; Klee, G.G.; Riggs, B.L. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen. J. Clin. Endocrinol. Metab. 1998, 83, 2266–2274. [Google Scholar] [CrossRef] [PubMed]
  77. Paliwal, P.; Pishesha, N.; Wijaya, D.; Conboy, I.M. Age dependent increase in the levels of osteopontin inhibits skeletal muscle regeneration. Aging 2012, 4, 553–566. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  78. Marks, R.; Allegrante, J.P.; Ronald MacKenzie, C.; Lane, J.M. Hip fractures among the elderly: Causes, consequences and control. Ageing Res. Rev. 2003, 2, 57–93. [Google Scholar] [CrossRef] [PubMed]
  79. Graafmans, W.C.; Ooms, M.E.; Hofstee, H.M.; Bezemer, P.D.; Bouter, L.M.; Lips, P. Falls in the elderly: A prospective study of risk factors and risk profiles. Am. J. Epidemiol. 1996, 143, 1129–1136. [Google Scholar] [CrossRef] [PubMed]
  80. Cheng, C.H.; Chen, L.R.; Chen, K.H. Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover. Int. J. Mol. Sci. 2022, 23, 1376. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  81. Armstrong, M.E.; Cairns, B.J.; Banks, E.; Green, J.; Reeves, G.K.; Beral, V.; Million Women Study, C. Different effects of age, adiposity and physical activity on the risk of ankle, wrist and hip fractures in postmenopausal women. Bone 2012, 50, 1394–1400. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  82. Hariri, A.F.; Almatrafi, M.N.; Zamka, A.B.; Babaker, A.S.; Fallatah, T.M.; Althouwaibi, O.H.; Hamdi, A.S. Relationship between Body Mass Index and T-Scores of Bone Mineral Density in the Hip and Spine Regions among Older Adults with Diabetes: A Retrospective Review. J. Obes. 2019, 2019, 9827403. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  83. Coin, A.; Sergi, G.; Beninca, P.; Lupoli, L.; Cinti, G.; Ferrara, L.; Benedetti, G.; Tomasi, G.; Pisent, C.; Enzi, G. Bone mineral density and body composition in underweight and normal elderly subjects. Osteoporos. Int. 2000, 11, 1043–1050. [Google Scholar] [CrossRef] [PubMed]
  84. Albertsson, D.; Gause-Nilsson, I.; Mellstrom, D.; Eggertsen, R. Risk group for hip fracture in elderly women identified by primary care questionnaire--clinical implications. Ups. J. Med. Sci. 2006, 111, 179–187. [Google Scholar] [CrossRef] [PubMed]
  85. Visentin, P.; Ciravegna, R.; Uscello, L.; Molaschi, M.; Fabris, F. Site-specific relative risk of fractures in the institutionalized elderly. Gerontology 1995, 41, 273–279. [Google Scholar] [CrossRef] [PubMed]
  86. Fujiwara, S.; Kasagi, F.; Masunari, N.; Naito, K.; Suzuki, G.; Fukunaga, M. Fracture prediction from bone mineral density in Japanese men and women. J. Bone Min. Res. 2003, 18, 1547–1553. [Google Scholar] [CrossRef] [PubMed]
  87. Singh, A.; Varma, A.R. Whole-Body Vibration Therapy as a Modality for Treatment of Senile and Postmenopausal Osteoporosis: A Review Article. Cureus 2023, 15, e33690. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  88. Beeram, I.; Mortensen, S.J.; Yeritsyan, D.; Momenzadeh, K.; von Keudell, A.; Nazarian, A. Multivitamins and risk of fragility hip fracture: A systematic review and meta-analysis. Arch. Osteoporos. 2021, 16, 29. [Google Scholar] [CrossRef] [PubMed]
Figure 1. PRISMA 2020 flow diagram.
Figure 1. PRISMA 2020 flow diagram.
Osteology 04 00006 g001
Figure 2. Forest plot demonstrating pooled effect size of age as a risk factor for osteoporotic hip fracture. Box and whiskers represent each study with its 95% confidence interval and the green diamond represents the overall effect size [6,10,18,19,20,21,22,23,24,29,32,33,34,36,39,41,43,44,47,48,49,50,52,53,57,59,60,61,62,63,65,69,71,74].
Figure 2. Forest plot demonstrating pooled effect size of age as a risk factor for osteoporotic hip fracture. Box and whiskers represent each study with its 95% confidence interval and the green diamond represents the overall effect size [6,10,18,19,20,21,22,23,24,29,32,33,34,36,39,41,43,44,47,48,49,50,52,53,57,59,60,61,62,63,65,69,71,74].
Osteology 04 00006 g002
Figure 3. Forest plot demonstrating pooled odds ratio of age as a risk factor for osteoporotic hip fracture. Box and whiskers represent each study with its 95% confidence interval and the red diamond represents the overall effect size. The red line serves as a reference point (OR = 1) against which the effects of individual studies are compared [11,32,38,42,64,66].
Figure 3. Forest plot demonstrating pooled odds ratio of age as a risk factor for osteoporotic hip fracture. Box and whiskers represent each study with its 95% confidence interval and the red diamond represents the overall effect size. The red line serves as a reference point (OR = 1) against which the effects of individual studies are compared [11,32,38,42,64,66].
Osteology 04 00006 g003
Figure 4. Forest plot demonstrating pooled odds ratio of sex as a risk factor for osteoporotic hip fracture. Box and whiskers represent each study with its 95% confidence interval and the green diamond represents the overall effect size. The red line serves as a reference point (OR = 1) against which the effects of individual studies are compared [6,11,18,20,22,23,27,38,39,40,42,43,47,48,51,52,55,56,63,69,71].
Figure 4. Forest plot demonstrating pooled odds ratio of sex as a risk factor for osteoporotic hip fracture. Box and whiskers represent each study with its 95% confidence interval and the green diamond represents the overall effect size. The red line serves as a reference point (OR = 1) against which the effects of individual studies are compared [6,11,18,20,22,23,27,38,39,40,42,43,47,48,51,52,55,56,63,69,71].
Osteology 04 00006 g004
Figure 5. Forest plot demonstrating pooled odds ratio of menopause status as a risk factor for osteoporotic hip fracture. Box and whiskers represent each study with its 95% confidence interval and the green diamond represents the overall effect size. The red line serves as a reference point (OR = 1) against which the effects of individual studies are compared [20,29].
Figure 5. Forest plot demonstrating pooled odds ratio of menopause status as a risk factor for osteoporotic hip fracture. Box and whiskers represent each study with its 95% confidence interval and the green diamond represents the overall effect size. The red line serves as a reference point (OR = 1) against which the effects of individual studies are compared [20,29].
Osteology 04 00006 g005
Figure 6. Forest plot demonstrating pooled odds ratio of ancestry as a risk factor for osteoporotic hip fracture. Box and whiskers represent each study with its 95% confidence interval and the diamonds represents the overall effect size. The red line serves as a reference point (OR = 1) against which the effects of individual studies are compared [10,25,37,54,61,64,66,68,71].
Figure 6. Forest plot demonstrating pooled odds ratio of ancestry as a risk factor for osteoporotic hip fracture. Box and whiskers represent each study with its 95% confidence interval and the diamonds represents the overall effect size. The red line serves as a reference point (OR = 1) against which the effects of individual studies are compared [10,25,37,54,61,64,66,68,71].
Osteology 04 00006 g006
Figure 7. Forest plot demonstrating pooled odds ratio of BMI as a risk factor for osteoporotic hip fracture. Box and whiskers represent each study with its 95% confidence interval and the red diamond represents the overall effect size. The red line serves as a reference point (OR = 1) against which the effects of individual studies are compared [17,31,33,47,52,64,68].
Figure 7. Forest plot demonstrating pooled odds ratio of BMI as a risk factor for osteoporotic hip fracture. Box and whiskers represent each study with its 95% confidence interval and the red diamond represents the overall effect size. The red line serves as a reference point (OR = 1) against which the effects of individual studies are compared [17,31,33,47,52,64,68].
Osteology 04 00006 g007
Figure 8. Forest plot demonstrating pooled odds ratio of parity status as a risk factor for osteoporotic hip fracture. Box and whiskers represent each study with its 95% confidence interval and the red diamond represents the overall effect size. The red line serves as a reference point (OR = 1) against which the effects of individual studies are compared [8,29,54].
Figure 8. Forest plot demonstrating pooled odds ratio of parity status as a risk factor for osteoporotic hip fracture. Box and whiskers represent each study with its 95% confidence interval and the red diamond represents the overall effect size. The red line serves as a reference point (OR = 1) against which the effects of individual studies are compared [8,29,54].
Osteology 04 00006 g008
Figure 9. Forest plot demonstrating pooled odds ratio of residential status as a risk factor for osteoporotic hip fracture. Box and whiskers represent each study with its 95% confidence interval and the red diamond represents the overall effect size. The red line serves as a reference point (OR = 1) against which the effects of individual studies are compared [11,12,14,22,23,26,48,63,73].
Figure 9. Forest plot demonstrating pooled odds ratio of residential status as a risk factor for osteoporotic hip fracture. Box and whiskers represent each study with its 95% confidence interval and the red diamond represents the overall effect size. The red line serves as a reference point (OR = 1) against which the effects of individual studies are compared [11,12,14,22,23,26,48,63,73].
Osteology 04 00006 g009
Figure 10. Forest plot demonstrating pooled odds ratio of history of falling and fractures as a risk factor for osteoporotic hip fracture. Box and whiskers represent each study with its 95% confidence interval and the red diamond represents the overall effect size. The red line serves as a reference point (OR = 1) against which the effects of individual studies are compared [6,12,14,17,24,29,33,40,41,42,45,46,54,61,66,67,68].
Figure 10. Forest plot demonstrating pooled odds ratio of history of falling and fractures as a risk factor for osteoporotic hip fracture. Box and whiskers represent each study with its 95% confidence interval and the red diamond represents the overall effect size. The red line serves as a reference point (OR = 1) against which the effects of individual studies are compared [6,12,14,17,24,29,33,40,41,42,45,46,54,61,66,67,68].
Osteology 04 00006 g010
Table 1. PICOS framework.
Table 1. PICOS framework.
ParameterDescription
PopulationIncludes both a healthy population and a population with hip fractures.
Intervention/ExposureInvolves examining a series of risk or protective factors associated with hip fractures.
ComparisonCompares patients with hip fractures to a healthy control population.
OutcomeFocuses on the occurrence of hip fractures as the primary outcome.
Study DesignEncompasses case–control and cohort studies.
Table 2. Characteristics of studies included in the meta-analysis.
Table 2. Characteristics of studies included in the meta-analysis.
StudyYearCountryType of StudyMean AgeSex (% Male)No. Patients with Hip fxNo. Patients w/o FractureNOS
Adams et al. [10]2018USACase–ControlNANA130614778
Al-Algawy et al. [11]2019IraqCase–ControlNA38751503
Albaba et al. [6]2012USARetrospective CohortNA4326512,3858
Albertsson et al. [12]2010SwedenProspective Cohort79.0072786
Anastasilakis et al. [13]2021GreeceCase–ControlNA037327
Anpalahan et al. [14]2014AustraliaCase–ControlNA292452457
Ardiansyah et al. [15]2019IndonesiaCase–Control75.12682827
Bartels et al. [16]2019NorwayCase–Control65.023501507
Bruin et al. [17]2020UKCohort81.32723,78044,5838
Chang et al. [18]2019TaiwanCohort74.1181661479
Chen et al. [19]2018TaiwanCase–Control77.901001007
Dai et al. [20]2018SingaporeCohort56.544250260,6529
Enns-Bray et al. [21]2019IcelandCase–Control77.30951597
Fan et al. [19]2018ChinaCase–Control74.402772727
Farahmand et al. [8]2000SwedenCase–Control71.50132732627
Fernandez-Ruiz et al. [22]2014SpainCohort74.34216651127
Fisher et al. [23]2017AustraliaCohort78.8334553857
Fox et al. [24]2000USACohort72.0050191909
Grisso et al. [25]1997USACase–ControlNA1003564027
Hansen et al. [26]2018DenmarkCase–Control73.93137,50037,5006
Holvik et al. [27]2019NorwayCohortNA49186533,2498
Hong et al. [28]2021South KoreaCase–Control71.4017722857
Huang et al. [29]1996USAProspective CohortNA013023838
Humbert et al. [30]2020SpainCase–Control68.9064647
Hundrup et al. [31]2005DenmarkCohortNA024514,0156
Hung et al. [32]2018TaiwanCase–Control75.4076276206
Hwang et al. [33]2011TaiwanCase–Control78.0253063066
Iki et al. [34]2021JapanCase–Control59.306812637
Jha et al. [35]2010IndiaCase–ControlNA431001008
Kauppi et al. [36]2014FinlandProspective Cohort66.4429622047
Khandelwal et al. [37]2012USARetrospective Cohort58.403971456
Kim et al. [38]2019South KoreaCohortNA39394386,0698
Komorita et al. [39]2020JapanCohort65.05711048136
Lam et al. [40]2020ChinaCohort83.939402119
Leslie et al. [41]2017CanadaCohort64.30136956,7397
Lin et al. [42]2020ChinaCohort68.224108867
Lin et al. [43]2021TaiwanCohort60.548206151,1679
Liu et al. [44]2017ChinaCase–Control73.90871747
Liu et al. [45]2020ChinaCase–Control65.002862867
Liu et al. [46]2021ChinaCase–Control70.326106410669
Lobo et al. [47]2016SpainCohort73.44227543859
Min et al. [48]2020South KoreaCohort61.44430682658
Muhlberg et al. [49]2019France and UKCohort75.9040556
Nakatoh et al. [50]2021JapanCohort84.6NA258448,7488
Papadimitriou et al. [51]2017Europe and USA (14 countries)CohortNA237724223,8808
Ramirez-Martin et al. [52]2017SpainCase–Control79.74050913157
Robbins et al. [53]2005FranceProspective CohortNA029373046
Robbins et al. [54]2007USACohortNA0113292,5447
Ruiz et al. [55]2019SpainCase–ControlNA2662495
Saribal et al. [56]2019TurkeyCase–Control70.53040407
Sarvi et al. [57]2019CanadaCase–Control75.40992946
Shalev et al. [58]2017IsaelCase–Control73.7042612789
Sharifi et al. [59]2018IranCase–Control69.710060605
Su et al. [60]2017ChinaCohort72.45012837457
Su et al. [61]2019USACohortNA10017258029
Takeshima et al. [62]2017JapanCohort79.3092487
Torbergsen et al. [63]2017NorwayCase–Control82.629116738
Turner et al. [64]1998USARetrospective Cohort68.8019521306
Valentini et al. [65]2018ItalyCohort79.1NA62507
Van den Eeden et al. [66]2003USACase–ControlNA05015338
Wainwright et al. [67]2005USACohortNA024378229
Weber Silva et al. [68]2017BrazilCase–Control76.0322132137
Wickramarachchi et al. [69]2021UKCohort59.449351036
Yang et al. [70]2018USACohort75.11001704868
Yu et al. [44]2017ChinaCase–Control68.9093507
Yu et al. [71]2021USACohort53.95220414,9947
Zhang et al. [72]2017ChinaCase–Control70.726105010507
Zhang et al. [73]2021USACohort74.24912741387
Zhuang et al. [74]2020ChinaCohort74.501351177
NOS: Newcastle–Ottawa Scale. NA: non-applicable.
Table 3. Publication bias was assessed through the Egger test. A. Categorical risk factors. B. Continuous risk factors.
Table 3. Publication bias was assessed through the Egger test. A. Categorical risk factors. B. Continuous risk factors.
Risk FactorBeta1SE of Beta1zp Value
A
Age−1.633.187−0.510.6085
Sex−0.760.465−1.620.1044
Ancestry−0.710.685−1.030.301
BMI0.561.7160.330.7448
Marital Status0.730.7910.920.3565
Parity0.510.9990.510.6129
History of Falling0.120.7670.160.8742
Previous Fracture1.611.2141.330.1843
Maternal Hip Fracture−0.382.338−0.160.8712
Parental Hip Fracture1.261.4450.870.3846
Residential Care Facility2.492.161.150.2496
Rural−0.320.771−0.420.6765
B
Age7.311.4235.130.00
Excluding studies with bias
−1.181.771−0.660.5063
BMI−10.441.662−6.280.00
Excluding studies with bias
−0.010.852−0.010.9945
Weight0.870.7541.150.2491
Height0.571.3830.410.6819
Table 4. Pooled odds ratios of risk factors with categorical data for sustaining a hip fracture.
Table 4. Pooled odds ratios of risk factors with categorical data for sustaining a hip fracture.
Risk FactorNumber of StudiesStudiesOdds Ratio (95% CI)p Value
Age≥653Al-Algawy (2019), Lin (2020), Turner (1998) [11,42,64]1.66 (0.40, 6.96)0.49
≥853Hung (2018), Kim (2019), Van den Eeden (2003) [32,38,66]1.75 (1.28, 2.38)<0.01
SexMale (reference) 1.00
Female21Al-Algawy (2019), Albaba (2012), Chang (2019), Dai (2018), Fernandez-Ruiz (2011), Fisher (2017), Holvik (2019), Kim (2019), Komorita (2020), Lam (2020), Lin (2021), Lin (2020), Lobo (2016), Min (2020), Papadimitriou (2017), Ramirez-Martin (2017), Ruiz (2019), Saribal (2019), Torbergsen (2017), Wickramarachchi (2021), and Yu (2021) [6,11,18,20,22,23,27,38,39,40,42,43,47,48,51,52,55,56,63,69,71]1.23 (1.15, 1.32)<0.01
AncestryWhite (reference) 1.00
Asian4Adams (2018), Khandelwal (2012), Robbins (2007), and Su (2019) [10,37,54,61]0.36 (0.27, 0.48)<0.01
Black8Adams (2018), Grisso (1997), Robbins (2007), Su (2019), Turner (1998), Van den Eeden (2003), Weber Silva (2017), and Yu (2021) [10,25,54,61,64,66,68,71]0.39 (0.23, 0.66)<0.01
Hispanic5Adams (2018), Robbins (2007), Su (2019), Turner (1998), and Yu (2021) [10,54,61,64,71]0.45 (0.33, 0.63)<0.01
Non-Caucasian9Adams (2018), Grisso (1997), Khandelwal (2012), Robbins (2007), Su (2019), Turner (1998), Van den Eeden (2003), Weber Silva (2017), and Yu (2021) [10,25,37,54,61,64,66,68,71]0.40 (0.31, 0.52)<0.01
BMINormal (reference) 1.00
Underweight6Bruin (2020), Hundrup (2005), Hwang (2011), Lobo (2016), Turner (1998), and Weber Silva (2017) [17,31,33,47,64,68]1.72 (1.35, 2.18)<0.01
Overweight6Bruin (2020), Hwang (2011), Lobo (2016), Ramirez-Martin (2017), Turner (1998), and Weber Silva (2017) [17,33,47,52,64,68]0.59 (0.45, 0.77)<0.01
Obese4Lobo (2016), Ramirez-Martin (2017), Turner (1998), and Weber Silva (2017) [47,52,64,68]0.38 (0.18, 0.77)0.01
Marital StatusMarried (reference) 1.00
Single and Unmarried5Farahmand (2000), Fernandez-Ruiz (2014), Grisso (1997), Hansen (2018), and Robbins (2007) [8,22,25,26,54]1.70 (1.38, 2.10)<0.01
Divorced6Al-Algawy (2019), Farahmand (2000), Fernandez-Ruiz (2014), Grisso (1997), Hansen (2018), and Robbins (2007) [8,11,22,25,26,54]1.38 (1.01, 1.89)0.05
Widowed7Al-Algawy (2019), Farahmand (2000), Fernandez-Ruiz (2014), Grisso (1997), Hansen (2018), Hwang (2011), and Robbins (2007) [8,11,22,25,26,33,54]1.36 (0.91, 2.03)0.13
Parity0 (reference) 1.00
≥13Farahmand (2000), Huang (1996), and Robbins (2007) [8,29,54]0.79 (0.69, 0.92)<0.01
≥1 and <33Farahmand (2000), Huang (1996), and Robbins (2007) [8,29,54]0.80 (0.71, 0.91)<0.01
≥33Farahmand (2000), Huang (1996), and Robbins (2007) [8,29,54]0.77 (0.63, 0.93)0.01
History of Falling12Albaba (2012), Albertsson (2010), Anpalahan (2014), Bruin (2020), Fox (2000), Hwang (2011), Lam (2020), Lin (2020), Liu (2020), Liu (2021), Su (2019), and Van den Eeden (2003) [6,12,14,17,24,33,40,42,45,46,61,66] 1.88 (1.43, 2.47)<0.01
Previous Fracture13Albaba (2012), Albertsson (2010), Anpalahan (2014), Bruin (2020), Huang (1996), Lam (2020), Leslie (2017), Lin (2020), Liu (2021), Robbins (2007), Su (2019), Wainwright (2005), and Weber Silva (2017) [6,12,14,17,29,40,41,42,46,54,61,67,68]3.16 (2.08, 4.80)<0.01
Menopause2Dai (2018) and Huang (1996) [20,29]7.21 (4.29, 12.12)<0.01
Family HistoryFamily History of Osteoporosis2Hundrup (2005) and Turner (1998) [31,64]0.95 (0.68, 1.34)0.77
Maternal Hip Fracture3Fox (2000), Turner (1998), and Zhang (2021) [24,64,73]1.63 (1.35, 1.98)<0.01
Parental Hip Fracture6Anpalahan (2014), Hwang (2011), Robbins (2007), Su (2019), Weber Silva (2017), and Zhang (2017) [14,33,54,61,68,72]1.42 (0.94, 2.15)0.10
EnvironmentalLiving Alone2Min (2020) and Zhang (2021) [48,73]1.47 (1.15, 1.89)<0.01
Residential Care Facility4Albertsson (2010), Anpalahan (2014), Fisher (2017), and Torbergsen (2017) [12,14,23,63]5.30 (1.91, 14.75)<0.01
Rural3Al-Algawy (2019), Fernandez-Ruiz (2014), and Hansen (2018) [11,22,26]0.95 (0.92, 0.98)<0.01
Income1st Quintile2Hansen (2018) and Shalev (2017) [26,58]0.86 (0.58, 1.28)0.46
2nd Quintile2Hansen (2018) and Shalev (2017) [26,58]0.76 (0.48, 1.22)0.26
3rd Quintile (reference) 1.00
4th Quintile2Hansen (2018) and Shalev (2017) [26,58]0.83 (0.56, 1.23)0.34
5th Quintile2Hansen (2018) and Shalev (2017) [26,58]0.65 (0.43, 1.00)0.05
Table 5. Pooled Cohen’s d values for hip fracture risk factors with continuous data.
Table 5. Pooled Cohen’s d values for hip fracture risk factors with continuous data.
Risk FactorNumber of Studies Cohen’s d (95% CI)p Value
Age34Adams (2018), Albaba (2012), Chang (2019), Dai (2018), Enns-Bray (2019), Fan (2018), Fernandez-Ruiz (2014), Fisher (2017), Fox (2000), Huang (1996), Hung (2018), Hwang (2011), Iki (2021), Kauppi (2014), Komorita (2020), Leslie (2017), Lin (2021), Lobo (2016), Min (2020), Muhlberg (2019), Nakatoh (2021), Ramirez-Martin (2017), Robbins (2005), Sarvi (2019), Sharifi (2018), Su (2019), Su (2017), Takeshima (2017), Torbergsen (2017), Valentini (2018), Wickramarachchi (2021), Yu (2017), Yu (2021), and Zhuang (2020) [6,10,18,19,20,21,22,23,24,29,32,33,34,36,39,41,43,44,47,48,49,50,52,53,57,59,60,61,62,63,65,69,71,74]0.63 (0.44, 0.82)<0.01
BMI26Adams (2018), Ardiansyah (2019), Bruin (2020), Chang (2019), Chen (2018), Dai (2018), Fan (2018), Farahmand (2000), Hong (2021), Huang (1996), Humbert (2020), Jha (2010), Komorita (2020), Leslie (2017), Liu (2017), Liu (2021), Lobo (2016), Min (2020), Su (2019), Su (2017), Takeshima (2017), Torbergsen (2017), Valentini (2018), Wainwright (2005), Yu (2021), and Zhuang (2020) [8,10,15,17,18,19,20,28,29,30,35,39,41,44,46,47,48,60,61,62,63,65,67,71,74]−0.29 (−0.37, −0.21)<0.01
Weight25Anpalahan (2014), Ardiansyah (2019), Chang (2019), Chen (2018), Enns-Bray (2019), Fan (2018), Fox (2000), Huang (1996), Humbert (2020), Iki (2021), Jha (2010), Kauppi (2014), Lam (2020), Leslie (2017), Liu (2021), Liu (2017), Muhlberg (2019), Robbins (2005), Robbins (2007), Sarvi (2019), Sharifi (2018), Su (2017), Takeshima (2017), Yang (2018), and Yu (2017) [14,15,18,19,21,24,29,30,34,35,36,40,41,44,46,49,53,54,57,59,60,62,70] −0.23 (−0.30, −0.15)<0.01
Height20Ardiansyah (2019), Chang (2019), Chen (2018), Enns-Bray (2019), Fan (2018), Fox (2000), Huang (1996), Humbert (2020), Iki (2021), Jha (2010), Kauppi (2014), Leslie (2017), Liu (2017), Muhlberg (2019), Robbins (2007), Sarvi (2019), Su (2017), Takeshima (2017), Yang (2018), and Yu (2017) [15,18,19,21,24,29,30,34,35,36,41,44,49,54,57,60,62,70]−0.00 (−0.13, 0.13)0.96
Menopause age2Chen (2018) and Hwang (2011) [19,33]−0.14 (−0.29, 0.02)0.09
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Yeritsyan, D.; Momenzadeh, K.; Mohamadi, A.; Mortensen, S.J.; Beeram, I.R.; Caro, D.; Kheir, N.; McNichol, M.; Wixted, J.J.; Appleton, P.; et al. Sociodemographic and Lifestyle Risk Factors Associated with Fragility Hip Fractures: A Systematic Review and Meta-Analysis. Osteology 2024, 4, 64-87. https://doi.org/10.3390/osteology4020006

AMA Style

Yeritsyan D, Momenzadeh K, Mohamadi A, Mortensen SJ, Beeram IR, Caro D, Kheir N, McNichol M, Wixted JJ, Appleton P, et al. Sociodemographic and Lifestyle Risk Factors Associated with Fragility Hip Fractures: A Systematic Review and Meta-Analysis. Osteology. 2024; 4(2):64-87. https://doi.org/10.3390/osteology4020006

Chicago/Turabian Style

Yeritsyan, Diana, Kaveh Momenzadeh, Amin Mohamadi, Sharri J. Mortensen, Indeevar R. Beeram, Daniela Caro, Nadim Kheir, Megan McNichol, John J. Wixted, Paul Appleton, and et al. 2024. "Sociodemographic and Lifestyle Risk Factors Associated with Fragility Hip Fractures: A Systematic Review and Meta-Analysis" Osteology 4, no. 2: 64-87. https://doi.org/10.3390/osteology4020006

APA Style

Yeritsyan, D., Momenzadeh, K., Mohamadi, A., Mortensen, S. J., Beeram, I. R., Caro, D., Kheir, N., McNichol, M., Wixted, J. J., Appleton, P., von Keudell, A., & Nazarian, A. (2024). Sociodemographic and Lifestyle Risk Factors Associated with Fragility Hip Fractures: A Systematic Review and Meta-Analysis. Osteology, 4(2), 64-87. https://doi.org/10.3390/osteology4020006

Article Metrics

Back to TopTop